ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Graalman Objects To Criticism On Contract Competition

April 22, 1977

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988

In Brief: Nearly One-Third Of Cancer Radiotherapy Facilities Use Outdated Methods – Clark

August 9, 1974

Score Distribution, Other Charts, On P01s

October 2, 1992

AACR President Coffey Urges Clinton to Support Doubling of NIH, NCI Budgets

December 19, 1997